Clinical trial NCT03601403: Tablet-assisted Training in Exacerbated COPD
Official title: Tablet-assisted Training as a Complement Hospital Intervention in Patients With Acute Exacerbations of COPD
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Chronic Obstructive Pulmonary Disease
Keywords: Education
Dry Powder Inhalers
Metered Dose Inhalers
Pulmonary Disease
Chronic Obstructive
Lead sponsor: Universidad de Granada
Sponsor class: OTHER
First posted: 2018-07-26
Enrollment: 42
Sex: ALL
Minimum age (years): 18
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: Chronic obstructive pulmonary disease (COPD) is a public health problem with great morbidity. The main therapeutic strategy is inhalers. The objective of this study is to determine the efficacy of a tablet-assisted training in the use of inhalers in patients with COPD including ventilatory re-education and video recordings of the patients themselves.

Detailed description: The importance of this pathology lies not only in its high prevalence, which is expected to increase due to the aging of society but also in its high mortality. In Europe, it is estimated that 50% of adult patients do not use the inhaler correctly. The clinical development of COPD includes periods of stability interspersed with symptomatic exacerbations, which usually involve hospitalization. During these hospitalizations, respiratory symptoms are worsening.Nevertheless, in Europe, it is estimated that 50% of adult patients do not use the inhaler correctly. Thus, it is very important the pharmacological education in this patients.

Eligibility criteria: Inclusion Criteria:

* Diagnosed of exacerbation of COPD.
* To possess pharmacological treatment in the form of inhalers.

Exclusion Criteria:

* Inability to provide informed consent.
* Presence of psychiatric or cognitive disorders.
* Organ failure or cancer.
* Inability to cooperate.
* Patients who had experienced an exacerbation in the last month.

Primary outcomes:
measure: Forced expiratory volume in the first second (FEV1)
timeFrame: [Time Frame: baseline, 12 months]
Secondary outcomes:
measure: Knowledge of the Chronic Obstructive Pulmonary Disease
timeFrame: [Time Frame: Baseline, 12 months]
measure: Cognitive Level
timeFrame: [Time Frame: Baseline]
measure: Functional independence
timeFrame: [Time Frame: Baseline]
measure: Anxiety-depression level
timeFrame: [Time Frame: Baseline, 12 months]
measure: Adhesion to inhalers
timeFrame: [Time Frame: Baseline]
measure: Dyspnea level
timeFrame: [Time Frame: Baseline]
measure: Physical fitness
timeFrame: [Time Frame: baseline, 12 months]
measure: Technique of the inhaler
timeFrame: [Time Frame: baseline, 12 months]
measure: Pressure expiratory force (PEF)
timeFrame: [Time Frame: baseline, 12 months]
Other outcomes:
Locations:
city: Granada.
country: Spain
facility: Faculty of Health Sciences. University of Granada.
state: Granada
Study officials:
affiliation: Department of Physical Therapy. University of Granada.
name: M. Carmen Valenza, PH MD
role: PRINCIPAL_INVESTIGATOR
References: